Abbey Donald 4

What Happened

• Abbey Donald, a director of ICU Medical (ICUI), received a grant of 1,475 restricted stock units (RSUs) and recorded an exercise/conversion of 1,254 derivative units on 2026-05-13. All transactions show $0.00 per share (no purchase or exercise price) and total cash value reported as $0.
• The filing shows both an acquisition via conversion (code M) of 1,254 shares and a same-day disposal of 1,254 shares (derivative). In addition, a separate grant/award (code A) for 1,475 RSUs was reported. These are awards/vestings rather than open-market purchases or sales.

Key Details

• Transaction date: 2026-05-13; Report filed: 2026-05-13 (timely).
• Transaction codes: M = exercise/conversion of derivative (1,254 shares acquired and 1,254 shares disposed), A = award/grant (1,475 RSUs acquired).
• Price: $0.00 per share for all reported items; total cash consideration listed as $0.
• Shares owned after transaction: Not disclosed in the provided filing.
• Footnotes: F1 — securities are Restricted Stock Units (RSUs). F2 — no purchase or exercise price for the RSUs. F3 — awards vest on the grant anniversary or the next annual stockholder meeting, whichever is earlier.
• No 10b5-1 plan, tax-withholding detail, or sale proceeds are specified in the provided data.

Context

• These transactions reflect equity awards and the conversion of derivative securities (RSUs) rather than an open-market buy or a straightforward sale. RSU grants are common compensation for directors; conversions and matching disposals can be used for vesting settlement, tax withholding, or immediate disposition, but the filing itself does not state the reason or any cash proceeds.
• For retail investors: awards (A) and conversions (M) are routine insider compensation events and do not necessarily signal a change in the insider’s view of the company.